Excipients are of vital importance in the process of drug development. A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for ...

The purpose of formulation development is to ensure that the drug is safe, effective, stable, and convenient to use. If the dosage form is improperly selected and if the prescription and process ...

(MENAFN- Market Press Release) November 2, 2021 7:16 am - Earlier this month, CD Formulation announced a decision to further optimize its custom excipient development services. Composed of a group of ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

One overarching consideration for the formulation of poorly soluble APIs for parenteral administration, stresses Shah, is that there is no one-size-fits-all excipient. “Studies are still ongoing that ...

One of the major challenges in working with excipients today is understanding, and adjusting to, complexity in materials and formulations. Pharmaceutical manufacturers today contend with such ...

The Nutraceutical Excipients Market is being driven by the growing global demand for dietary supplements, functional foods, and fortified nutrition products. Rising consumer focus on preventive ...

WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, a pharmaceutical technology company developing innovative platforms to improve biologic formulations, expanded its patent portfolio with the issuance ...

(MENAFN- Market Press Release) July 4, 2022 1:03 am - CD Formulation recently announced a comprehensive range of binder excipients that can be used in pharmaceutical research. Excipients play a ...

New York, July 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional ...

Earlier this month, CD Formulation has announced its capability to precisely measure the contact angle of pharmaceutical excipients. NY, UNITED STATES, August 19 ...